Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus

por Bays, Harold E, Weinstein, Richard, Law, Gordon, Canovatchel, William
Publicado 2014

Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic Impairment

por Mercier, Anne-Kristina, Sunnåker, Mikael, Ueckert, Sebastian, Pawlik, Tadeusz, Henricson, Emilia, Molodetskyi, Oleksandr, Law, Gordon C., Parker, Victoria E. R., Oscarsson, Jan
Publicado 2023

Design of FLAIR: a Phase 2b Study of the 5-Lipoxygenase Activating Protein Inhibitor AZD5718 in Patients With Proteinuric CKD

por Heerspink, Hiddo J.L., Law, Gordon, Psachoulia, Konstantina, Connolly, Kathleen, Whatling, Carl, Ericsson, Hans, Knöchel, Jane, Lindstedt, Eva-Lotte, MacPhee, Iain
Publicado 2021

Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials

por Neal, Bruce, Perkovic, Vlado, Mahaffey, Kenneth W., Fulcher, Greg, Erondu, Ngozi, Desai, Mehul, Shaw, Wayne, Law, Gordon, Walton, Marc K., Rosenthal, Norm, de Zeeuw, Dick, Matthews, David R.
Publicado 2017